News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OSI Pharmaceuticals, Inc. (OSIP) Bid Likely to Rise as Astellas Pharma Inc. (JOBS) Seeks Cancer Sales


3/9/2010 7:04:59 AM

Bloomberg -- OSI Pharmaceuticals Inc.’s status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astellas Pharma Inc. must pay to acquire it.

Read at Business Week
Read at Seeking Alpha
Read at BNET


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES